KLBF – In collaboration with GC Cell

KLBF – In collaboration with GC Cell Kalbe Farma (KLBF) through its subsidiary, Bifarma Adiluhung, collaborates with GC Cell to develop a cell therapy business with the aim of facilitating the entry of Immuncell-LC in Indonesia. Immuncell-LC is an autologous T cell therapy innovation that has been approved for use in liver cancer surgery in Korea. The collaboration also includes technology transfer and cooperation in the development of a Natural Killer Cells therapy pipeline that effectively kills cancer cells. (Source : Kontan)